These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22834924)

  • 1. Insulin resistance and polycystic ovary syndrome through life.
    Diamanti-Kandarakis E; Spritzer PM; Sir-Petermann T; Motta AB
    Curr Pharm Des; 2012; 18(34):5569-76. PubMed ID: 22834924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children.
    Kamangar F; Okhovat JP; Schmidt T; Beshay A; Pasch L; Cedars MI; Huddleston H; Shinkai K
    Pediatr Dermatol; 2015; 32(5):571-8. PubMed ID: 25787290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome.
    Nandi A; Chen Z; Patel R; Poretsky L
    Endocrinol Metab Clin North Am; 2014 Mar; 43(1):123-47. PubMed ID: 24582095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: a preliminary investigation].
    Li TT; Xu LZ; Chen YH; Deng HM; Liang CY; Liu Y; Liu XF; Zhang J; Kang DY; Qiu DS; Han DW; Hu R
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1753-6. PubMed ID: 22027783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome in adolescence.
    Buggs C; Rosenfield RL
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):677-705, x. PubMed ID: 16085166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome and environmental toxins.
    Rutkowska AZ; Diamanti-Kandarakis E
    Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S; McCarthy MI; Hardy K
    Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of polycystic ovary syndrome in childhood and adolescence.
    Ojaniemi M; Tapanainen P; Morin-Papunen L
    Horm Res Paediatr; 2010; 74(5):372-5. PubMed ID: 20861609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult polycystic ovary syndrome begins in childhood.
    Franks S
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):263-72. PubMed ID: 12064892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.
    Caserta D; Adducchio G; Picchia S; Ralli E; Matteucci E; Moscarini M
    Gynecol Endocrinol; 2014 Jun; 30(6):397-402. PubMed ID: 24552422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of environmental factors and polycystic ovary syndrome].
    Huang WJ; Liu JY; Li LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):302-4. PubMed ID: 17673040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.
    Ovalle F; Azziz R
    Fertil Steril; 2002 Jun; 77(6):1095-105. PubMed ID: 12057712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome: the influence of environmental and genetic factors.
    Diamanti-Kandarakis E; Piperi C; Spina J; Argyrakopoulou G; Papanastasiou L; Bergiele A; Panidis D
    Hormones (Athens); 2006; 5(1):17-34. PubMed ID: 16728382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients.
    Luo Y; Nie Y; Tang L; Xu CC; Xu L
    Medicine (Baltimore); 2020 Mar; 99(11):e19444. PubMed ID: 32176075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of obesity and polycystic ovary syndrome in adolescents.
    Vilmann LS; Thisted E; Baker JL; Holm JC
    Horm Res Paediatr; 2012; 78(5-6):269-78. PubMed ID: 23208318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.